Literature DB >> 8425703

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.

J H Lefkowitch1, E R Schiff, G L Davis, R P Perrillo, K Lindsay, H C Bodenheimer, L A Balart, T J Ortego, J Payne, J L Dienstag.   

Abstract

BACKGROUND: Hepatic histological responses described in hepatitis C virus (HCV) infection include bile duct damage, lymphoid follicles and/or aggregates in portal tracts, large- and small-droplet fat, Mallory body-like material in hepatocytes, liver cell dysplasia and multinucleation, and activation of sinusoidal inflammatory cells. The specificity of these lesions for HCV infection is uncertain.
METHODS: In two multicenter trials of recombinant interferon alfa therapy for chronic hepatitis C and B, the frequency of these eight lesions in pretherapy and posttherapy liver biopsy specimens was examined to determine the set of features, if any, that distinguishes HCV from hepatitis B virus (HBV) infection. The lesions were scored in 317 HCV biopsy specimens and 299 HBV specimens.
RESULTS: Stepwise logistic regression determined a set of three features more likely to be seen in HCV than in HBV infection: bile duct damage [odds ratio (OR), 4.7; 95% confidence interval (Cl), 1.8-12.3], lymphoid follicles and/or aggregates (OR, 2.4; 95% Cl, 1.2-4.7), and large-droplet fat (OR, 2.4; 95% Cl, 1.4-4.1). A fourth lesion, Mallory body-like material, was seen only in HCV biopsy specimens (OR, 71.6; 95% Cl, 4.4-996.1).
CONCLUSIONS: These four histological lesions are useful pathological parameters in the diagnosis of liver disease caused by HCV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425703     DOI: 10.1016/0016-5085(93)90432-c

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  54 in total

1.  Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.

Authors:  E Giannini; F Botta; A Fasoli; P Romagnoli; L Mastracci; P Ceppa; I Comino; A Pasini; D Risso; R Testa
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

Authors:  A B Jazwinski; A J Thompson; P J Clark; S Naggie; H L Tillmann; K Patel
Journal:  J Viral Hepat       Date:  2011-11-24       Impact factor: 3.728

Review 3.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Histological features predictive of liver fibrosis in chronic hepatitis C infection.

Authors:  V Paradis; P Mathurin; A Laurent; F Charlotte; M Vidaud; T Poynard; C Hoang; P Opolon; P Bedossa
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  Effect of interferon therapy on bile duct inflammation in hepatitis C.

Authors:  B F Banner; C Allan; L Smith; L Savas; H L Bonkovsky
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

6.  Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.

Authors:  N Kumagai; S Kuramochi; K Toda; N Iwabuchi; K Tsuchimoto; S Tsunematsu; H Saito; T Morizane; M Tsuchiya; H Ishii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

7.  Hepatitis C and bile duct loss.

Authors:  R D Goldin; N K Patel; H C Thomas
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 8.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

9.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

10.  Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus.

Authors:  Kohichiroh Yasui; Yuichi Harano; Hironori Mitsuyoshi; Kazuhiro Tsuji; Mio Endo; Tomoaki Nakajima; Masahito Minami; Yoshito Itoh; Yoh Zen; Yasuni Nakanuma; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.